Theravance Biopharma shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Theravance Biopharma
Tip: Access up to 7 years of quarterly data
All positions including Theravance Biopharma held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Theravance Biopharma by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $517k | 46k | 11.25 |
| 2023-09-30 | $415k | 48k | 8.64 |
| 2023-06-30 | $445k | 43k | 10.35 |
| 2023-03-31 | $412k | 38k | 10.87 |
| 2022-12-31 | $415k | 37k | 11.23 |
| 2022-03-31 | $434k | 45k | 9.56 |
| 2021-12-31 | $454k | 41k | 11.06 |
| 2021-09-30 | $374k | 51k | 7.40 |
| 2021-06-30 | $520k | 36k | 14.51 |
| 2021-03-31 | $771k | 38k | 20.41 |
| 2020-12-31 | $7.9M | 447k | 17.77 |
| 2020-09-30 | $8.0M | 544k | 14.79 |
| 2020-06-30 | $11M | 525k | 20.99 |
| 2020-03-31 | $12M | 515k | 23.11 |
| 2019-12-31 | $14M | 526k | 25.89 |
| 2019-09-30 | $10M | 524k | 19.48 |
| 2019-06-30 | $19M | 1.1M | 16.33 |
| 2019-03-31 | $28M | 1.2M | 22.67 |
| 2018-12-31 | $32M | 1.2M | 25.59 |
| 2018-09-30 | $52M | 1.6M | 32.67 |
| 2018-06-30 | $40M | 1.7M | 22.68 |
| 2018-03-31 | $57M | 2.3M | 24.25 |
| 2017-12-31 | $65M | 2.3M | 27.89 |
| 2017-06-30 | $53M | 1.3M | 39.84 |
| 2017-03-31 | $13M | 363k | 36.82 |
| 2016-12-31 | $9.2M | 288k | 31.88 |
| 2016-09-30 | $11M | 315k | 36.24 |
| 2016-06-30 | $4.8M | 211k | 22.69 |
| 2016-03-31 | $2.3M | 124k | 18.80 |
| 2015-12-31 | $2.2M | 136k | 16.39 |
| 2015-09-30 | $1.5M | 140k | 10.99 |
| 2015-03-31 | $2.2M | 124k | 17.35 |
| 2014-12-31 | $5.1M | 343k | 14.92 |
| 2014-06-30 | $3.3M | 104k | 31.88 |